These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 24529855)

  • 1. The role of KIR2DS1 in multiple sclerosis--KIR in Portuguese MS patients.
    Bettencourt A; Silva AM; Carvalho C; Leal B; Santos E; Costa PP; Silva BM
    J Neuroimmunol; 2014 Apr; 269(1-2):52-5. PubMed ID: 24529855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Killer immunoglobulin-like receptor ligand HLA-Bw4 protects against multiple sclerosis.
    Lorentzen AR; Karlsen TH; Olsson M; Smestad C; Mero IL; Woldseth B; Sun JY; Senitzer D; Celius EG; Thorsby E; Spurkland A; Lie BA; Harbo HF
    Ann Neurol; 2009 Jun; 65(6):658-66. PubMed ID: 19630074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIRs and their HLA ligands in remitting-relapsing multiple sclerosis.
    Fusco C; Guerini FR; Nocera G; Ventrella G; Caputo D; Valentino MA; Agliardi C; Gallotti J; Morra VB; Florio C; Clerici M; Lombardi ML
    J Neuroimmunol; 2010 Dec; 229(1-2):232-7. PubMed ID: 20826009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients.
    García-León JA; Pinto-Medel MJ; García-Trujillo L; López-Gómez C; Oliver-Martos B; Prat-Arrojo I; Marín-Bañasco C; Suardíaz-García M; Maldonado-Sanchez R; Fernández-Fernández O; Leyva-Fernández L
    Mol Immunol; 2011 Sep; 48(15-16):1896-902. PubMed ID: 21665278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
    Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
    Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple sclerosis associates with LILRA3 deletion in Spanish patients.
    Ordóñez D; Sánchez AJ; Martínez-Rodríguez JE; Cisneros E; Ramil E; Romo N; Moraru M; Munteis E; López-Botet M; Roquer J; García-Merino A; Vilches C
    Genes Immun; 2009 Sep; 10(6):579-85. PubMed ID: 19421224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population.
    Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B
    J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory KIR and specific HLA-C gene combinations confer susceptibility to or protection against chronic hepatitis B.
    Gao X; Jiao Y; Wang L; Liu X; Sun W; Cui B; Chen Z; Zhao Y
    Clin Immunol; 2010 Oct; 137(1):139-46. PubMed ID: 20643584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective role of the HLA-A*02 allele in Portuguese patients with multiple sclerosis.
    Silva AM; Bettencourt A; Pereira C; Santos E; Carvalho C; Mendonça D; Costa PP; Monteiro L; Martins B
    Mult Scler; 2009 Jun; 15(6):771-4. PubMed ID: 19482867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
    Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
    Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparate distribution of activating and inhibitory killer cell immunoglobulin-like receptor genes in patients with systemic lupus erythematosus.
    Hou YF; Zhang YC; Jiao YL; Wang LC; Li JF; Pan ZL; Yang QR; Sun HS; Zhao YR
    Lupus; 2010 Jan; 19(1):20-6. PubMed ID: 19926642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Killer immunoglobulin-like receptor and their HLA ligands in Guillain-Barré Syndrome.
    Blum S; Csurhes P; Reddel S; Spies J; McCombe P
    J Neuroimmunol; 2014 Feb; 267(1-2):92-6. PubMed ID: 24367901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the killer cell immunoglobulin-like receptor gene KIR2DS1 in a Caucasoid Brazilian population with psoriasis vulgaris.
    Jobim M; Jobim LF; Salim PH; Cestari TF; Toresan R; Gil BC; Jobim MR; Wilson TJ; Kruger M; Schlottfeldt J; Schwartsmann G
    Tissue Antigens; 2008 Oct; 72(4):392-6. PubMed ID: 18643961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
    Clausen J; Kircher B; Auberger J; Schumacher P; Ulmer H; Hetzenauer G; Wolf D; Gastl G; Nachbaur D
    Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KIR genes and HLA class I ligands in Gaucher disease.
    Vairo F; Portela P; Salim PH; Jobim M; Netto C; Dorneles A; Mittlestadt S; Jobim LF; Schwartz IV
    Gene; 2013 Mar; 516(1):53-7. PubMed ID: 23266622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of killer cell immunoglobulin-like receptor genes with Hodgkin's lymphoma in a familial study.
    Besson C; Roetynck S; Williams F; Orsi L; Amiel C; Lependeven C; Antoni G; Hermine O; Brice P; Ferme C; Carde P; Canioni D; Brière J; Raphael M; Nicolas JC; Clavel J; Middleton D; Vivier E; Abel L
    PLoS One; 2007 May; 2(5):e406. PubMed ID: 17476328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
    Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
    Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
    Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIR2DS3 is associated with protection against acute myeloid leukemia.
    Shahsavar F; Tajik N; Entezami KZ; Fallah Radjabzadeh M; Asadifar B; Alimoghaddam K; Ostadali Dahaghi M; Jalali A; Ghashghaie A; Ghavamzadeh A
    Iran J Immunol; 2010 Mar; 7(1):8-17. PubMed ID: 20371915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of Killer cell immunoglobulin like receptor genes in end stage renal disease among North Indian population.
    Prakash S; Alam S; Sharma RK; Sonawane A; Imran M; Agrawal S
    Hum Immunol; 2013 Oct; 74(10):1339-45. PubMed ID: 23777934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.